NCT06747091 - ARIADNE Clinical Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 18, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

March 1, 2027

Conditions

Persistent Atrial Fibrillation

Interventions

PROCEDURE

Catheter Ablation

This is a prospective randomized clinical trial. Patients will undergo catheter ablation for persistent AF using a lattice-tip catheter that can switch between RFA and PFA energy. Enrolled patients will be randomized to one of three ablation strategies:

Trial Locations (3)

10075

RECRUITING

Kristie Coleman, New York

11030

RECRUITING

North Shore University Hospital, Manhasset

11040

RECRUITING

Long Island Jewish Medical Center, New Hyde Park

All Listed Sponsors

lead

Stavros E Mountantonakis

OTHER